SRE Holdings (2980) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
5 Aug, 2026Executive summary
Net sales doubled year-over-year to JPY 8,488.9 million, driven by strong growth in both AI & LS and L & P segments, with operating profit surging to JPY 1,812.4 million from JPY 92.4 million a year earlier.
Profit attributable to owners of parent reversed from a loss to JPY 1,113.3 million, and EBITDA rose to JPY 1,996 million.
Organizational restructuring unified real estate consulting and cloud solutions, aligning with a strategic focus on industry-specific AI and BPaaS.
Financial highlights
Net sales: JPY 8,488.9 million (+100.2% YoY); Operating profit: JPY 1,812.4 million (+1,869.6% YoY); EBITDA: JPY 1,996 million (+610.3% YoY); Profit attributable to owners: JPY 1,113.3 million (from -19 million YoY).
Ordinary profit reached JPY 1,681 million (+5,322.6% YoY); gross profit rose to JPY 3,700.9 million from JPY 1,610.7 million YoY.
Basic EPS improved to JPY 69.08 from negative JPY 1.21 YoY.
Equity ratio stable at 31.1%; total assets increased to JPY 51,814.4 million.
Dividend per share maintained at JPY 20.0; ROE tracking toward 12%.
Outlook and guidance
FY2026 net sales forecast at JPY 41,800 million (+27.2% YoY), operating profit at JPY 5,230 million (+25.1% YoY), and profit attributable to owners at JPY 2,830 million (+53.8% YoY); EPS JPY 167.58.
Strategic reinvestment of JPY 0.4 billion planned, with record-high profits expected across all levels.
No change to previously announced dividend policy or earnings guidance.
AI & LS and PT segments expected to drive high-margin growth; L & P profit to decline due to prior-year one-off gains.
Latest events from SRE Holdings
- Record-setting sales and profit growth, with double-digit gains and margin improvement forecast.2980
Q4 202613 May 2026 - Record profit and revenue growth driven by AI and real estate, with strong outlook.2980
Q3 202610 Feb 2026 - Profits fell sharply, but AI and healthcare segments grew; strong 2H recovery expected.2980
Q2 202611 Nov 2025 - Sales declined and a net loss was posted, but AI Cloud & Consulting showed strong growth.2980
Q1 20268 Sep 2025 - Strong sales and profit growth driven by segment expansion and Medix acquisition.2980
Q1 20258 Sep 2025 - Double-digit sales and profit growth, boosted by Medix acquisition and segment expansion.2980
Q2 20258 Sep 2025 - Sales up 12.6% but profit down 31.7%; Medix acquisition drives asset and goodwill growth.2980
Q3 20258 Sep 2025 - Strong revenue and profit growth with FY2026 guidance projecting over 30% increases.2980
Q4 20258 Sep 2025